Article Details

Mereo BioPharma Offered to Settle Proxy Contest with Rubric - GlobeNewswire

Retrieved on: 2022-09-26 11:01:37

Tags for this article:

Click the tags to see associated articles and topics

Mereo BioPharma Offered to Settle Proxy Contest with Rubric - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2022/09/26/2522356/0/en/Mereo-BioPharma-Offered-to-Settle-Proxy-Contest-with-Rubric-Capital-Management-by-Putting-Rubric-Principal-and-Second-New-Director-on-the-Board.html

Excerpt

LONDON, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or the “Company”), a clinical-stage biopharmaceutical ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up